-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Cuts, cuts, cuts, cuts, cuts, cuts going to get worse and we are all next. We all now know the new order doesn't know jack sh#_ except cuts, never ask questions, thinks they know it all. Ha..typical frog. Dust off and brush up the resume.
Remember, it's always about profit, not sales.
If profits are at an acceptable level due to decreased expenses because tm's are staying home I would not be surprised if some cuts come in the fourth quarter
Why pay for an outside sales force when the company can make acceptable profits with a reduced sales force or even no sales force?
After all, everything Ceva sells his OTC except for the heartworm in the NSAID
If profits are at an acceptable level due to decreased expenses because tm's are staying home I would not be surprised if some cuts come in the fourth quarter
Why pay for an outside sales force when the company can make acceptable profits with a reduced sales force or even no sales force?
After all, everything Ceva sells his OTC except for the heartworm in the NSAID
We are unnecessary and looked at as overhead. Several in my region want out. 
Please stop whining and complaining. Yes, it sucks. Stop cashing company checks and then bitching about it. Either hit the road or stay and do your job without jumping on here.
RM in training d-bag. You better hope you don't work for me. This place is full of spoiled babies, or to say it another way, French. You are being paid to stay home chubby cheeks. See if you can get on with Bayer.